Customized Compounding for Molluscum Contagiosum

Promoting Rapid Resolution and Minimizing Discomfort

Molluscum contagiosum is a viral skin infection that manifests as small, raised bumps on the skin. It is a common condition, especially in children, and can cause distress and discomfort. At our compounding pharmacy, we offer customized topical treatments specifically formulated to address molluscum contagiosum. By incorporating antiviral agents, immunomodulators, and keratolytic agents, these compounded compounds can expedite the resolution of molluscum lesions while minimizing discomfort and reducing the risk of scarring.

Antiviral Agents

Antiviral agents are key components in compounded treatments for molluscum contagiosum. They work by inhibiting viral replication and reducing the spread of the virus. Some commonly used antiviral agents include:

  • Imiquimod: Imiquimod is an immune response modifier that activates the body’s immune system to fight against viral infections. It stimulates the production of cytokines, such as interferons, which have antiviral properties. Imiquimod also enhances the activity of immune cells, such as macrophages and dendritic cells, to recognize and eliminate infected cells. (Reference: FDA prescribing information)

  • Cidofovir: Cidofovir is a potent antiviral agent that directly inhibits viral DNA replication. It works by selectively targeting viral polymerases, enzymes essential for viral DNA synthesis. Cidofovir has demonstrated efficacy against various viral infections, including molluscum contagiosum. (Reference: Journal of Clinical Virology)


Immunomodulators are substances that modulate or regulate the immune response. In the context of molluscum contagiosum, immunomodulators help stimulate the body’s immune system to recognize and eliminate the viral infection. Some commonly used immunomodulators include:

  • Cantharidin: Cantharidin is a natural compound derived from blister beetles and is known for its keratolytic and immunomodulatory properties. It helps dissolve the molluscum lesions and stimulates an immune response against the virus. Cantharidin is usually applied topically in low concentrations to avoid excessive blistering or skin irritation. (Reference: Journal of Drugs in Dermatology)

Keratolytic Agents

Keratolytic agents aid in the removal of dead skin cells and promote the shedding of the molluscum lesions. This process allows for quicker resolution and healing. One commonly used keratolytic agent is:

  • Salicylic Acid: Salicylic acid is a beta-hydroxy acid that exfoliates the skin by dissolving the bonds between dead skin cells. It helps to remove the top layer of the skin, including the molluscum lesions, facilitating their resolution. Salicylic acid also possesses anti-inflammatory properties, which can help reduce discomfort and inflammation associated with molluscum contagiosum. (Reference: Journal of the American Academy of Dermatology)

At our compounding pharmacy, we understand the unique needs of patients with molluscum contagiosum. By utilizing the advantages of compounding, we can create customized topical treatments that incorporate these ingredients in precise formulations tailored to the individual patient’s needs. Our compounded compounds offer the potential for faster resolution of molluscum lesions, reduced discomfort, and minimized scarring.

Please note that these are sample ingredients commonly used in compounded treatments for molluscum contagiosum. The specific ingredients and formulations used may vary based on the healthcare provider’s prescription and patient’s individual requirements. It is always important to consult with a healthcare professional for personalized treatment recommendations.

At Reliant Compounded Solutions, we prioritize the safety and well-being of every patient we serve. While we strive to create customized compounded formulations to address the specific needs of pediatric patients with eczema, it is important to note that not all ingredients may be compatible with every individual.

We understand the complexities of each patient’s medical history, allergies, and sensitivities. Therefore, we advise healthcare providers to reach out to us directly for more information regarding specific ingredients, potential interactions, or any other concerns they may have. Our team of knowledgeable pharmacists can provide additional guidance and support to ensure the most suitable treatment options for their patients.

For more information or to discuss specific cases, please contact us at 203.262.8000 or email us at We are committed to working collaboratively with healthcare providers to provide the best possible solutions for pediatric patients with eczema, aiming to alleviate symptoms, improve skin health, and enhance overall well-being.

At Reliant Compounded Solutions, we are dedicated to providing customized compounded formulations and supporting healthcare providers in their efforts to meet the unique needs of each individual patient.